In addition to their effects on glucose regulation, GLP-1 and GIP have cardiovascular actions, including improvements in endothelial function, reduction in oxidative stress, and anti-inflammatory effects, which are potentially advantageous in heart failure management [8,9]. Here, GLP1R is linked to heart failure.